Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tomasz Obrzut
Laboratory Correlates for a Phase II Trial of Romidepsin in Cutaneous and Peripheral T-Cell Lymphoma
British Journal of Haematology
Hematology
Related publications
Romidepsin: Evidence for Its Potential Use to Manage Previously Treated Cutaneous T Cell Lymphoma
Core Evidence
Medicine
Reviews
References
Pharmacology
A Phase Ii Trial of Brentuximab Vedotin (Bv) and Lenalidomide (Len) in Relapsed and Refractory (R/R) Cutaneous (Ctcl) and Peripheral (Ptcl) T-Cell Lymphomas: Preliminary Results of a Phase Ii Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase II Study of Gemcitabine and Bexarotene (GemBex) in the Treatment of Cutaneous T-Cell Lymphoma
Phase I Study of Romidepsin and Liposomal Doxorubicin in Relapsed or Refractory T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Nodal Peripheral T-Cell Lymphoma With Secondary Granulomatous Cutaneous Involvement
Acta Dermato-Venereologica
Dermatology
Medicine
Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma
Clinical Case Reports
Medicine
Phase Ii Fil-Ptcl13 Study of Romidepsin-Choep Followed by High-Dose Chemotherapy and Transplantation in Untreated Peripheral T-Cell Lymphomas
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PRELIMINARY RESULTS OF ASTX660, a NOVEL NON-PEPTIDOMIMETIC cIAP1/2 AND XIAP ANTAGONIST, IN RELAPSED/REFRACTORY PERIPHERAL T-Cell LYMPHOMA AND CUTANEOUS T CELL LYMPHOMA
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase 1 Study of Pralatrexate Plus Romidepsin Reveals Marked Activity in Patients With Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (Ptcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
